Aprogen has a total of 102 patents globally, out of which 71 have been granted. Of these 102 patents, more than 53% patents are active. Korea (South) is where Aprogen has filed the maximum number of patents, followed by the USA and Canada. Parallelly, Korea (South) seems to be the main focused R&D center and also Korea is the origin country of Aprogen.
Aprogen was founded in the year 1971. The Company operates as a biopharmaceutical company. The Company focuses on developing and manufacturing biosimilar products, new protein drugs, and bispecific antibodies. Aprogen serves customers worldwide.
Do read about some of the most popular patents of Aprogen which have been covered by us in this article and also you can find Aprogen patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Aprogen patent portfolio.
How many patents does Aprogen have?
Aprogen has a total of 102 patents globally. These patents belong to 29 unique patent families. Out of 102 patents, 55 patents are active.
How Many Patents did Aprogen File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Aprogen Applications Filed||Aprogen Patents Granted|
How many Aprogen patents are Alive/Dead?
How Many Patents did Aprogen File in Different Countries?
Countries in which Aprogen Filed Patents
|United States Of America||18|
Where are Research Centers of Aprogen Patents Located?
10 Best Aprogen Patents
WO2003080672A1 is the most popular patent in the Aprogen portfolio. It has received 179 citations so far from companies like Amgen Inc, AbbVie, and Abbott.
Below is the list of 10 most cited patents of Aprogen:
|Publication Number||Citation Count|
What Percentage of Aprogen US Patent Applications were Granted?
Aprogen (Excluding its subsidiaries) has filed 9 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 9 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Aprogen patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Aprogen?
|Law Firm||Total Applications||Success Rate|
|Clark & Elbing Llp||1||100.00%|
|Lathrop Gpm Llp||1||100.00%|